Skip to content

Assessment of microcirculation, myocardial damage, inflammatory response in sepsis patients and its correlation with prognosis

Assessment of microcirculation, myocardial damage, inflammatory response in sepsis patients and its correlation with prognosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048192
Enrollment
Unknown
Registered
2021-07-04
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Case series:No

Sponsors

Zhongshan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Sepsis patients in the emergency department 2. There is no restriction on gender, over 18 years old; 3. Sepsis diagnostic criteria (sepsis3.0): meet the following 2 requirements at the same time (1) Patients who are infected or suspected of being infected; (2) The degree of change in the patient's SOFA score >= 2 points.

Exclusion criteria

Exclusion criteria: 1. Patients with advanced renal insufficiency or long-term need for hemodialysis treatment; 2. Use drugs that can stimulate the release of cellular inflammatory mediators; 3. During lactation or pregnant women; 4. Patients with acute or chronic skin diseases or burns; 5. Patients with abnormal intelligence or mental state; 6. Patients who are unwilling to participate in this study.

Design outcomes

Primary

MeasureTime frame
Procalcitonin;C-reactive protein;White blood cell;Tumor necrosis factor;Interleukin-1ß;Interleukin-2 receptor;Interleukin-6;Interleukin-8;Interleukin-10; High-sensitivity cardiac troponin T;

Countries

China

Contacts

Public ContactYao Chenling

Zhongshan Hospital Affiliated to Fudan University

zhou.yannan@zs-hospital.sh.cn+86 15801719404

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026